NL-OMON24783招募中不适用
Metastatic hormone-sensitive and castration resistant prostate cancer registry: CAPRI 3.0
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients who were treated in a participating hospital after 01-01-2016 and have:
- •- metastatic HSPC, defined as involvement of lymph nodes, bones or viscera on radiological assessment or as defined by either the treating doctor/physician (i.e. palliative treatment with surgical or medical castration)
- •- metastatic CRPC, defined by the treating doctor/physician or the definition of the European Urology Association (EAU)[10], as prostate cancer that is progressing despite medical or surgical castration (i.e. castrate levels of testosterone (= 50 ng/dL or <1.7 nmol/L)
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Treatment of patients with castration-resistant metastatic prostate cancer with nuclear medicine procedureCastration resistant metastatic prostate cancer.Malignant neoplasm of prostateIRCT20180113038331N1Mashhad University of Medical Sciences20
尚未招募
2 期
Targeted a-Therapy in Prostate CancerProstate cancer.Malignant neoplasm of prostateIRCT20210612051548N1Boushehr University of Medical Sciences10
已完成
不适用
Hormonal therapy resistant estorgen receptor positive metastatic breast cancer cohort studyBreast cancerJPRN-UMIN000019556General Incorporated Association of CSPOR-BC200
Unknown
3 期
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor TherapyBreast CancerNCT00688194Gruppo Italiano Mammella (GIM)396
进行中（未招募）
1 期
Response evaluation with 68Ga-PSMA PET of metastatic prostate cancer castration resistant patients in treatment with 223RaCl2Patients mCRPC eligible to treatment with 223RaCl2MedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10005993Term: Bone metastasesSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.1Level: LLTClassification code 10036223Term: Positron emission tomographySystem Organ Class: 100000004848MedDRA version: 21.1Level: PTClassification code 10062904Term: Hormone-refractory prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-001395-38-ITAZIENDA USL DELLA VALLE D'AOSTA50